[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"undifferentiated-carcinoma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:undifferentiated-carcinoma":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100563181","development-of-tumor-organoids-from-undifferentiated-primary-carcinomas-to-guide-therapeutic-decisions-100563181",false,"NCT06612827","Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions","OCAPI","Inclusion Criteria:\n\n* Patient with undifferentiated primary carcinoma (UPC) with histological and immunohistochemical evidence, validated in a local and\u002For national UPC multidisciplinary consultation\n* Patient with indication for systemic 1st-line treatment at the time of inclusion. Treatment may already have begun at the time of inclusion, but within the limit of 2 treatment cycles administered.\n* Patient with life expectancy greater than 3 months\n* Patient of legal age\n* Patient affiliated to a social security scheme\n* Signature of informed consent prior to any specific study procedure\n\nExclusion Criteria:\n\n* Persons deprived of their liberty or under guardianship (including curatorship)\n* Pregnant or breast-feeding patient","ALL","18 Years",{"count":19,"type":20},20,"ESTIMATED","OBSERVATIONAL","The study is based on the constitution of a collection of tumor and blood samples for the development of tumoroid for functional tests to predict clinical response to treatment.",[24],"Undifferentiated Carcinoma",[26,27],"tumoroid","organoid","RECRUITING","2025-12-23",{"date":31,"type":32},"2025-12-24","ACTUAL",{"date":34,"type":32},"2025-03-05",{"date":36,"type":20},"2032-12-15",{"name":38,"class":39},"Centre Francois Baclesse","OTHER"]